NutriDex

The Supplement Research Compendium

🧈

Butyrate (Tributyrin)

Butyric acid

Gut-cell fuel marketed for colitis and metabolic health.

Mixed evidence 🛡️Gut & Immune
Evidence tier
Mixed
Research weight
Citations
7 verified / 7
Classification
Gut & Immune
What the evidence says. Graded mixed: butyrate is the main fuel for colon cells with sound biology, but trials conflict — adults with ulcerative colitis and IBS often improve when it is added to standard care or paired with probiotics/fiber, yet a multicenter pediatric IBD RCT and human stress trials were flatly negative, and most positive results are small, short, or use combination products. (Mixed evidence: Conflicting results across studies; benefit uncertain.)

What is Butyrate (Tributyrin)?

Butyrate (Tributyrin) (Butyric acid) is a gut and immune supplement used for support gut barrier. NutriDex grades the human evidence as Mixed. Butyrate is a short-chain fatty acid your gut bacteria make when they ferment fiber; it is the primary energy source for colon lining cells and has anti-inflammatory effects. Supplements deliver it as sodium/calcium butyrate salts or tributyrin (a glyceride prodrug), usually microencapsulated to reach the colon. Human trials are genuinely split. In adults with ulcerative colitis, butyrate added to mesalazine and a recent 140-patient IBD trial showed better activity scores, calprotectin and quality of life, and a 120-patient IBS study found higher symptom relief (about 65% vs 42%) — but that used butyrate plus probiotics and fiber. Against this, a multicenter pediatric IBD RCT (300 mg/day) found no benefit over placebo, and colon-delivered butyrate did not blunt the cortisol stress response in healthy men. Metabolic effects on blood sugar are small and mostly appear with co-supplements. Promising for the gut, not yet convincing.

Purported Benefits

Support gut barrier
Add-on for ulcerative colitis
Ease IBS symptoms (in combinations)
Modest blood-sugar support

Evidence by outcome

The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.

OutcomeEvidenceEffectStudies
Ulcerative colitis / IBD activityAdult add-on trials show benefit in IBD activity/calprotectin, but a pediatric RCT was null; results genuinely split. Mixed ↔ mixed 3
IBS symptom reliefOne n=120 RCT showed 65% vs 42% relief, but butyrate was combined with probiotics + FOS, so attribution is unclear. Preliminary ↑ benefit · moderate 1
Blood-sugar / fasting glucoseGlucose fell only when butyrate was paired with inulin; standalone metabolic effect not established. Preliminary ↔ mixed · small 1
Stress / cortisol responseAn SCFA mixture blunted cortisol, but butyrate alone did not affect acute stress in a later RCT. Mixed ↔ mixed · negligible 2

Dosing & Compounds

Typical Dose
Microencapsulated sodium butyrate 300–600 mg/day (active), or tributyrin 0.2–4 g/day; gut-targeted forms are used to survive the upper GI tract.
Active Compounds
Butyric acid (short-chain fatty acid)Sodium/calcium butyrate saltsTributyrin (glyceride prodrug)

Safety & Cautions

Oral butyrate is generally well tolerated; the most common complaints are mild GI upset, bloating and a foul taste/odor (tributyrin and salts smell of rancid butter), which microencapsulation reduces. No serious adverse events were reported in IBD/IBS trials and no specific drug interactions are established, but because butyrate may lower blood glucose and modestly affect GLP-1, people on antidiabetic drugs (insulin, sulfonylureas) should monitor for additive lowering. It is an adjunct, not a replacement for prescribed colitis therapy; safety in pregnancy, breastfeeding and young children is not well studied, so use under clinician guidance. Educational only — always check with your doctor or pharmacist before combining Butyrate (Tributyrin) with any medicine.

Common questions about Butyrate (Tributyrin)

What is Butyrate (Tributyrin) used for?

Butyrate (Tributyrin) is most often taken for Support gut barrier, Add-on for ulcerative colitis, Ease IBS symptoms (in combinations), Modest blood-sugar support. Gut-cell fuel marketed for colitis and metabolic health.

Does Butyrate (Tributyrin) work — what does the evidence say?

Mixed evidence. Conflicting results across studies; benefit uncertain. Butyrate is a short-chain fatty acid your gut bacteria make when they ferment fiber; it is the primary energy source for colon lining cells and has anti-inflammatory effects. Supplements deliver it as sodium/calcium butyrate salts or tributyrin (a glyceride prodrug), usually microencapsulated to reach the colon. Human trials are genuinely split. In adults with ulcerative colitis, butyrate added to mesalazine and a recent 140-patient IBD trial showed better activity scores, calprotectin and quality of life, and a 120-patient IBS study found higher symptom relief (about 65% vs 42%) — but that used butyrate plus probiotics and fiber. Against this, a multicenter pediatric IBD RCT (300 mg/day) found no benefit over placebo, and colon-delivered butyrate did not blunt the cortisol stress response in healthy men. Metabolic effects on blood sugar are small and mostly appear with co-supplements. Promising for the gut, not yet convincing.

What is the typical dose of Butyrate (Tributyrin)?

Microencapsulated sodium butyrate 300–600 mg/day (active), or tributyrin 0.2–4 g/day; gut-targeted forms are used to survive the upper GI tract.

Is Butyrate (Tributyrin) safe? Any cautions or side effects?

Oral butyrate is generally well tolerated; the most common complaints are mild GI upset, bloating and a foul taste/odor (tributyrin and salts smell of rancid butter), which microencapsulation reduces. No serious adverse events were reported in IBD/IBS trials and no specific drug interactions are established, but because butyrate may lower blood glucose and modestly affect GLP-1, people on antidiabetic drugs (insulin, sulfonylureas) should monitor for additive lowering. It is an adjunct, not a replacement for prescribed colitis therapy; safety in pregnancy, breastfeeding and young children is not well studied, so use under clinician guidance.

How many studies support Butyrate (Tributyrin)?

NutriDex cites 7 sources for Butyrate (Tributyrin), graded "Mixed".

Cite this page
APA

Peh, D. (2026). Butyrate (Tributyrin) (Butyric acid): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 26 Jun 2026, from https://nutridex.info/s/butyrate

BibTeX
@misc{nutridex_butyrate,
  author       = {Peh, Daryl},
  title        = {Butyrate (Tributyrin) (Butyric acid): Benefits, Dosage, Side Effects \& Evidence},
  year         = {2026},
  howpublished = {NutriDex --- The Supplement Research Compendium},
  url          = {https://nutridex.info/s/butyrate},
  note         = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-06-26}
}

For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.

← Back to the full dex · All substances